Form 4 for CYTK CYTOKINETICS INC
Accepted 2025-12-05 00:00:00 ET · period of report 2025-12-05 · accession 0001061983-25-000048 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-05 | 2025-12-05 | CYTK | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $33.84 | +52.5K | 92.5K | +131% | +$1.78M |
| D | 2025-12-05 | 2025-12-05 | CYTK | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $65.95 | -52.5K | 50.7K | -51% | -$3.46M |
| DM | 2025-12-05 | 2025-12-05 | CYTK | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $0.00 | -52.5K | 36.4K | -59% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-05 | M | A | 10,628 | $37.63 | 103,146 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-05 | M | A | 15,000 | $23.26 | 65,660 | D | — | — | |
| 3 | Common | Common Stock | 2025-12-05 | M | A | 11,000 | $39.13 | 76,660 | D | — | — | |
| 4 | Common | Common Stock | 2025-12-05 | M | A | 15,858 | $37.63 | 92,518 | D | — | — | |
| 5 | Common | Common Stock | 2025-12-05 | S | D | 52,486 | $65.95 | 50,660 | D | — | — | |
| 6 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2025-12-05 | M | D | 15,858 | $0.00 | 15,857 | D | $37.63 · 2025-04-01 to 2032-03-01 | 15,858 Common Stock | |
| 7 | Derivative | Incentive Stock Option (Right to Buy) | 2025-12-05 | M | D | 10,628 | $0.00 | 2,657 | D | $37.63 · 2025-04-01 to 2032-03-01 | 10,628 Common Stock | |
| 8 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2025-12-05 | M | D | 15,000 | $0.00 | 114,000 | D | $23.26 · 2022-03-31 to 2031-03-31 | 15,000 Common Stock | |
| 9 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2025-12-05 | M | D | 11,000 | $0.00 | 36,445 | D | $39.13 · 2023-04-06 to 2033-03-06 | 11,000 Common Stock |